Three hundred and nine malignant endometrial tumors were biochemically analyzed with
respect to estrogen (ER) and progesterone (PR) receptors. Fifty-seven percent of …

Estradiol receptors (ER) were measured in 71 and progesterone receptors (PR) in 62
primary endometrial carcinomas. ER were found in 62 (87%) and PR in 56 (90%) of the …

Eighty-six cases of primary endometrial carcinoma were assayed for the presence or
absence of cytoplasmic estrogen and progesterone receptors by the saturation point …

The history of research on oestrogen and progestin receptors in endometrial cancer goes
back about 20 years. Summarized data from several clinical studies demonstrate that cytosol …

Background. Endometrial carcinoma is the most common femalé pelvic genital malignancy.
Many studies suggest that approximately 75% of all endometrial cancers are clinical Stage I …

One hundred eighty-three patients with endometrial carcinoma had both
immunohistochemical and biochemical analysis of estrogen receptor (ER) and progesterone …

The survival of 213 postmenopausal patients with primary endometrial cancer was analyzed
as a function of clinicopathologic features and cytosol steroid receptor levels. Estrogen …

A series of 183 cases of primary endometrial carcinomas were immunohistochemically
stained for estrogen receptors (ERs) and progesterone receptors (PRs) using formalin-fixed …

Cytosol progestin (PR) and estrogen receptor (ER) concentrations were measured in 114
endometrial carcinoma specimens from 109 patients; these levels were correlated with …

Concentrations of cytosol estrogen (ERC) and cytosol progestin (PRC) receptors were
assayed in malignant tissue specimens of 230 patients with endometrial cancer, and those …